<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8"/>
    <meta property="og:url" content="https://www.moneycontrol.com/news/business/lupin-launches-generic-skin-inflammation-treatment-cream-in-us-4665801.html"/>
    <meta property="og:site_name" content="Moneycontrol"/>
    <meta property="article:published_time" content="2019-11-22T00:00:00+00:00"/>
    <meta property="og:title" content="Lupin launches generic skin inflammation treatment cream in US"/>
    <meta property="og:description" content="The company has launched Hydrocortisone Valerate cream USP, 0.2 per cent, having received approval from the United States Food and Drug Administration (USFDA) earlier, Lupin said in a statement."/>
  </head>
  <body>
    <article>
      <h1>Lupin launches generic skin inflammation treatment cream in US</h1>
      <h2>The company has launched Hydrocortisone Valerate cream USP, 0.2 per cent, having received approval from the United States Food and Drug Administration (USFDA) earlier, Lupin said in a statement.</h2>
      <address><time datetime="2019-11-22T00:00:00+00:00">22 Nov 2019</time> by <a rel="author">PTI</a></address>
      <p>Drug firm <a href="http://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/lupin/L">Lupin</a> onÂ November 22 said it has launched its generic Hydrocortisone Valerate cream USP, used for treatment of inflammation and itching of skin, in the US market.</p>
      <p>The company has launched Hydrocortisone Valerate cream USP, 0.2 per cent, having received approval from the United States Food and Drug Administration (USFDA) earlier, Lupin said in a statement.</p>
      <p>The product is the generic version of Sun Pharmaceutical Industries Inc's Westcort cream in the same strength, it added.</p>
      <p>According to IQVIA MAT September 2019 data, Hydrocortisone Valerate Cream USP, 0.2 per cent had annual sales of around USD 11.5 million in the US, Lupin said.</p>
      <p>The product is "indicated for the relief of the Inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in adult patients," it added.</p>
      <p>Shares of Lupin Ltd closed at Rs 773.30 on BSE, up 0.33 per cent from its previous close.</p>
    </article>
  </body>
</html>